BioNTech SE (BNTX) Long-Term Investments (2018 - 2025)

BioNTech SE (BNTX) has 7 years of Long-Term Investments data on file, last reported at $87.8 million in Q3 2025.

• In Q3 2025, Long-Term Investments changed N/A year-over-year to $87.8 million; the TTM figure through Sep 2025 stood at $87.8 million (changed N/A YoY), while the FY2023 annual figure was $1.2 billion, up 561.12% from the prior year.
• Long-Term Investments declined to $87.8 million in Q3 2025, from $101.9 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $1.2 billion in Q4 2023 and bottomed at $24.4 million in Q4 2021.
• A 5-year average of $220.0 million and a median of $101.9 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments surged 637.76% — and 2025, when it plunged 73.49%.
• Year by year, Long-Term Investments stood at $24.4 million in 2021, then surged by 637.76% to $179.8 million in 2022, then surged by 561.12% to $1.2 billion in 2023, then slumped by 79.77% to $240.4 million in 2024, then slumped by 63.48% to $87.8 million in 2025.
• The last three Long-Term Investments figures came in at $87.8 million (Q3 2025), $101.9 million (Q2 2025), and $63.7 million (Q1 2025), per Business Quant data.

Peer Comparison